Status:
COMPLETED
PREDHICT: Precision Recruitment and Engagement of Diabetics and Hypertensives in Clinical Studies
Lead Sponsor:
NYU Langone Health
Conditions:
Cardiovascular Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
For the sub-study, this digital navigation tool will both inform/educate, engage, support, and navigate participants and providers through the process of clinical trial participation via personalizati...
Detailed Description
To identify provider- and system-level facilitators (solutions) of clinical trial participation that can be in corporated in the digital navigation tool. We will pay special emphasis on the behavior r...
Eligibility Criteria
Inclusion
- NYU and/or Bellevue patient
- Diagnosed with HTN and pre-diabetes/diabetes
- Must be English speakers
- Ownership of a smart phone and are willing to use it to download app built in TrialX which will be free for participants
- Must be ambulatory
Exclusion
- are unable or unwilling to provide informed consent;
- are unable to participate meaningfully in an intervention that involves self-- monitoring using software available in English (e.g., due to uncorrected sight impairment, illiterate, non-English-speaking, dementia);
- are institutionalized (e.g., in a nursing home or personal care facility, or those who - are incarcerated and have limited control over self-management)
- have a history of heart disease, kidney disease, or retinopathy (to rule-out those with long-standing, undiagnosed T2D)
Key Trial Info
Start Date :
October 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 27 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04286113
Start Date
October 20 2020
End Date
October 27 2021
Last Update
December 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone
New York, New York, United States, 10016